tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

NRSN Stock Latest News

NeuroSense Therapeutics Secures Continued Nasdaq Listing
Company AnnouncementsNeuroSense Therapeutics Secures Continued Nasdaq Listing
1d ago
6K
NRSN
Neurosense Therapeutics Secures $30 Million Equity Deal
PremiumCompany Announcements
Neurosense Therapeutics Secures $30 Million Equity Deal
13d ago
6K
NRSN
NeuroSense Completes Key ALS Trial Phase
PremiumCompany Announcements
NeuroSense Completes Key ALS Trial Phase
15d ago
6K
NRSN
NeuroSense Therapeutics Advances ALS Drug Development Plans
PremiumCompany Announcements
NeuroSense Therapeutics Advances ALS Drug Development Plans
17d ago
6K
NRSN
NeuroSense to meet with FDA for Phase 3 ALS trial and NDA submission
PremiumThe Fly
NeuroSense to meet with FDA for Phase 3 ALS trial and NDA submission
17d ago
NRSN
NeuroSense’s PrimeC Shows Potential in ALS Treatment
PremiumCompany AnnouncementsNeuroSense’s PrimeC Shows Potential in ALS Treatment
21d ago
6K
NRSN
NeuroSense’s PrimeC shows microRNA improvement in ALS
Premium
The Fly
NeuroSense’s PrimeC shows microRNA improvement in ALS
21d ago
NRSN
NeuroSense Targets Key ALS Drug Market in Canada
Premium
Company Announcements
NeuroSense Targets Key ALS Drug Market in Canada
30d ago
6K
NRSN
NeuroSense Targets Early ALS Drug Approval in Canada
PremiumCompany Announcements
NeuroSense Targets Early ALS Drug Approval in Canada
1M ago
6K
NRSN
NeuroSense to file for early commercialization of ALS treatment in Canada
PremiumThe Fly
NeuroSense to file for early commercialization of ALS treatment in Canada
1M ago
NRSN
NeuroSense Therapeutics Reports Mid-Year Financials
PremiumCompany Announcements
NeuroSense Therapeutics Reports Mid-Year Financials
1M ago
6K
NRSN
NeuroSense Back on Track with NASDAQ Compliance
PremiumCompany Announcements
NeuroSense Back on Track with NASDAQ Compliance
2M ago
6K
NRSN
NeuroSense granted U.S. patent for PrimeC in ALS
PremiumThe FlyNeuroSense granted U.S. patent for PrimeC in ALS
2M ago
NRSN
NeuroSense Embarks on HIPAA Compliance Journey
Premium
Company Announcements
NeuroSense Embarks on HIPAA Compliance Journey
2M ago
6K
NRSN
NeuroSense Reports Positive Drug Study Results
Premium
Company Announcements
NeuroSense Reports Positive Drug Study Results
2M ago
6K
NRSN
NeuroSense Therapeutics Faces Nasdaq Non-Compliance Notice
PremiumCompany Announcements
NeuroSense Therapeutics Faces Nasdaq Non-Compliance Notice
3M ago
6K
NRSN
NeuroSense Eyes Lucrative Pharma Partnerships for ALS Drug
PremiumCompany Announcements
NeuroSense Eyes Lucrative Pharma Partnerships for ALS Drug
3M ago
6K
NRSN
NeuroSense Therapeutics Gains Nasdaq Extension
PremiumCompany Announcements
NeuroSense Therapeutics Gains Nasdaq Extension
3M ago
6K
NRSN
NeuroSense Therapeutics Announces Share Issuance
PremiumCompany Announcements
NeuroSense Therapeutics Announces Share Issuance
3M ago
6K
NRSN
NeuroSense Therapeutics Announces Strategic Securities Sale
PremiumCompany AnnouncementsNeuroSense Therapeutics Announces Strategic Securities Sale
3M ago
6K
NRSN
NeuroSense’s ALS Drug Shows Promise in Trial
Premium
Company Announcements
NeuroSense’s ALS Drug Shows Promise in Trial
3M ago
6K
NRSN
NeuroSense’s PrimeC shows positive biomarker data from ALS Phase 2b trial
Premium
The Fly
NeuroSense’s PrimeC shows positive biomarker data from ALS Phase 2b trial
3M ago
NRSN

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >